- Product Details
Keywords
- Decitabine
- 2353-33-5
- high purity Decitabine
Quick Details
- ProName: High Quality Raw Material Decitabine P...
- CasNo: 2353-33-5
- Appearance: White powder
- Application: Decitabine (NSC 127716) is a DNA methy...
- DeliveryTime: 3-7 days
- PackAge: Independent sealed packaging
- Port: Shanghai port TIanjin port Qingdao por...
- ProductionCapacity: 10000 Kilogram/Month
- Purity: 99%
- Storage: seal preservation
- Transportation: by sea or by air
- LimitNum: 1 Kilogram
Superiority
1.Fast and safety delivery by well-reputed shipping line;
2.we have our own chemical laboratory and factory
3.Reasonable price, excellent quality and attentive service.
4.prompt reply.we can reply your inquiry within 12 hours.
5.sample free(depends on product,we just collect courier fee, or give us your express account NO.)
6.Rich experience in loading a great amount of containers
7.Sperior quality and good package
8.The product and package can be customed according cusomter's requirement.
Details
High Quality Raw Material Decitabine powder CAS 2353-33-5 Decitabine
Product Name | High Quality Raw Material Decitabine powder CAS 2353-33-5 Decitabine |
Appearance | white powder |
Molecular formula | C8h12n4o4 |
Molecular Weight | 228.20 |
Keywords | Raw Material Decitabine;Decitabine powder;Decitabine |
Shelf Life | 24 months when properly stored |
Storage | Keep in a cool, dry, dark location |
What is Decitabine Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, is adrug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML).Chemically, it is a cytidine analog. Decitabine is a hypomethylating agent.It hypomethylates DNA by inhibiting DNA methyltransferase. It functions in a similar manner to azacitidine, although decitabine can only be incorporated into DNA strands while azacitidine can be incorporated into both DNA and RNA chains. |
Function of Decitabine
High Quality Raw Material Decitabine powder CAS 2353-33-5 Decitabine
Application of Decitabine
Decitabine is indicated for the treatment of myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia,refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and Intermediate-1, Intermediate-2, and High-Risk International Prognostic Scoring System groups. In patients with renal insufficiency, Batty and colleagues reported the first case series on the feasibility of therapy with hypomethylating agents in patients with renal insufficiency.